CMY-29 and CMY-30, two novel plasmid-mediated AmpC beta-lactamases.
Pope
Christopher E
CE
Carter
Philip E
PE
Heffernan
Helen M
HM
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002440:Cefoxitin / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics; D004927:Escherichia coli Infections / Q000382:microbiology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D008969:Molecular Sequence Data; D009520:New Zealand; D010957:Plasmids / Q000235:genetics*; D001618:beta-Lactamases / Q000235:genetics* / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D002440:Cefoxitin; D001618:beta-Lactamases